NIH-funded research NIH-funded research

Developing a real-time monitoring system for ultra-fast radiation therapy

Official title: FY24 SBIR PHASE IITOPIC NO. 434PROJECT TITLE: ULTRA-RAID RF-BASED BEAM MONITOR FOR REAL-TIME FLASH BEAM CONTROL

Funded at Tibaray, INC. · NIH-11202593 · Data updated 2026-11-12

This study is working on improving a new type of cancer treatment called FLASH radiation therapy by developing a special system that can quickly monitor and adjust the radiation dose during treatment, making it safer and more effective for patients.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionTibaray, INC.
NIH-funded
Lab location1 site (Santa Clara, UNITED STATES)
Project startSeptember 16, 2024
Project endSeptember 15, 2026
Funding year2024
Award (this year)$1,999,956
NIH project number75N91024C00096-0-9999-1
Project IDNIH-11202593 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are patients undergoing radiation therapy for cancer who may benefit from advanced treatment methods.

Less likely to help

Patients who are not receiving radiation therapy or those with conditions that do not require such treatment may not benefit from this research.

What this research studies

This research focuses on advancing ultra-fast FLASH radiation therapy (FLASH-RT) for cancer treatment by creating a real-time beam monitoring system. The project aims to build and test linear accelerators equipped with RF-based monitors that can measure radiation doses in microseconds and adjust the beam accordingly. By integrating user feedback and ensuring the system's reliability, the researchers hope to enhance the safety and effectiveness of FLASH-RT in clinical settings.

Why it matters

Potential benefit: If successful, this research could lead to safer and more effective cancer treatments through improved radiation therapy techniques.

How similar studies have gone: Previous studies have shown promise in the use of FLASH radiation therapy, indicating that this approach could lead to significant advancements in cancer treatment.

Where this research is happening

  • Tibaray, INC.
    Santa Clara, United States
    Active

Researchers

  • Principal investigator: Toufexis, Filippos — Tibaray, INC.
  • Study coordinator: Toufexis, Filippos

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.